PortfoliosLab logoPortfoliosLab logo
RNIN vs. SMRI
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

RNIN vs. SMRI - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Bushido Capital US SMID Cap Equity ETF (RNIN) and Bushido Capital US Equity ETF (SMRI). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, RNIN achieves a 15.44% return, which is significantly higher than SMRI's 12.23% return.


RNIN

1D
0.62%
1M
1.26%
YTD
15.44%
6M
14.30%
1Y
27.06%
3Y*
5Y*
10Y*

SMRI

1D
-0.89%
1M
1.02%
YTD
12.23%
6M
10.92%
1Y
26.23%
3Y*
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

RNIN vs. SMRI - Yearly Performance Comparison


2026 (YTD)2025
RNIN
Bushido Capital US SMID Cap Equity ETF
15.44%10.92%
SMRI
Bushido Capital US Equity ETF
12.23%15.44%

Correlation

The correlation between RNIN and SMRI is 0.84, indicating a strong positive relationship between their price movements. Combining them offers limited diversification - they tend to fall together during downturns.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.84

Correlation (All Time)
Calculated using the full available price history since May 15, 2025

0.84

The correlation between RNIN and SMRI has been stable across timeframes, ranging from 0.84 to 0.84 - a consistent structural relationship.

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

RNIN vs. SMRI — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

RNIN
RNIN Risk / Return Rank: 7171
Overall Rank
RNIN Sharpe Ratio Rank: 6060
Sharpe Ratio Rank
RNIN Sortino Ratio Rank: 6363
Sortino Ratio Rank
RNIN Omega Ratio Rank: 5757
Omega Ratio Rank
RNIN Calmar Ratio Rank: 8989
Calmar Ratio Rank
RNIN Martin Ratio Rank: 8585
Martin Ratio Rank

SMRI
SMRI Risk / Return Rank: 6363
Overall Rank
SMRI Sharpe Ratio Rank: 5656
Sharpe Ratio Rank
SMRI Sortino Ratio Rank: 5757
Sortino Ratio Rank
SMRI Omega Ratio Rank: 5454
Omega Ratio Rank
SMRI Calmar Ratio Rank: 8181
Calmar Ratio Rank
SMRI Martin Ratio Rank: 6666
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

RNIN vs. SMRI - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Bushido Capital US SMID Cap Equity ETF (RNIN) and Bushido Capital US Equity ETF (SMRI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


RNINSMRIDifference
Sharpe ratioReturn per unit of total volatility

+0.09

Sortino ratioReturn per unit of downside risk

+0.17

Omega ratioGain probability vs. loss probability

1.32

1.31

+0.01

Calmar ratioReturn relative to maximum drawdown

4.77

3.87

+0.90

Martin ratioReturn relative to average drawdown

15.88

11.00

+4.87

RNIN vs. SMRI - Sharpe Ratio Comparison

The current RNIN Sharpe Ratio is 1.82, which is comparable to the SMRI Sharpe Ratio of 1.73. The chart below compares the historical Sharpe Ratios of RNIN and SMRI, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

RNIN vs. SMRI - Drawdown Comparison

The maximum RNIN drawdown since its inception was -5.70%, smaller than the maximum SMRI drawdown of -18.45%. Use the drawdown chart below to compare losses from any high point for RNIN and SMRI.


Loading charts...

Drawdown Indicators


RNINSMRIDifference

Max Drawdown

Largest peak-to-trough decline

-5.70%

-18.45%

+12.75%

Max Drawdown (1Y)

Largest decline over 1 year

-5.70%

-6.80%

+1.10%

Current Drawdown

Current decline from peak

-2.96%

-6.47%

+3.51%

Average Drawdown

Average peak-to-trough decline

-1.30%

-2.74%

+1.44%

Ulcer Index

Depth and duration of drawdowns from previous peaks

1.71%

2.39%

-0.68%

Volatility

RNIN vs. SMRI - Volatility Comparison

The current volatility for Bushido Capital US SMID Cap Equity ETF (RNIN) is 4.83%, while Bushido Capital US Equity ETF (SMRI) has a volatility of 7.26%. This indicates that RNIN experiences smaller price fluctuations and is considered to be less risky than SMRI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


RNINSMRIDifference

Volatility (1M)

Calculated over the trailing 1-month period

4.83%

7.26%

-2.43%

Volatility (6M)

Calculated over the trailing 6-month period

10.65%

11.74%

-1.09%

Volatility (1Y)

Calculated over the trailing 1-year period

14.98%

15.25%

-0.27%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

14.89%

15.95%

-1.06%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

14.89%

15.95%

-1.06%

RNIN vs. SMRI - Expense Ratio Comparison

RNIN has a 0.68% expense ratio, which is lower than SMRI's 0.71% expense ratio.


Dividends

RNIN vs. SMRI - Dividend Comparison

RNIN's dividend yield for the trailing twelve months is around 0.77%, less than SMRI's 1.00% yield.


PositionTTM202520242023
RNIN
Bushido Capital US SMID Cap Equity ETF
0.77%0.71%0.00%0.00%
SMRI
Bushido Capital US Equity ETF
1.00%1.32%0.98%0.45%

Frequently Asked Questions


RNIN and SMRI have a correlation of 0.84, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

SMRI has higher volatility (7.26%) compared to RNIN (4.83%). In terms of maximum drawdown, RNIN dropped -5.70% vs SMRI's -18.45%.

On 1-year performance, RNIN leads with 27.06% vs 26.23% for SMRI. On fees, RNIN is cheaper at 0.68% per year. On volatility, RNIN has been the lower-risk option at 4.83%. The better choice depends on whether you care most about return, fees, risk, or income.

Over the 1-year period, RNIN has performed better with a 27.06% return vs 26.23%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

RNIN is cheaper with a 0.68% expense ratio, compared with 0.71% for SMRI.

SMRI has the higher dividend yield at 1.00%, compared with 0.77% for RNIN.

RNIN is categorized as Mid Cap Value Equities, while SMRI is Large Cap Value Equities. Their fees differ too: 0.68% for RNIN and 0.71% for SMRI.

RNIN currently has the higher Sharpe Ratio (1.82 vs 1.73), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for RNIN and SMRI

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer